Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Flower power: geranium scent may help cancer patients during chemo

NCT ID NCT07292844

Symptom relief Sponsor: Universitas Muhammadiyah Surakarta Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether inhaling geranium essential oil during chemotherapy can reduce pain and blood pressure in cancer patients. 90 Indonesian patients under 65 with normal weight took part. The treatment group breathed in geranium oil for 15 minutes during chemo, while the control group received usual care. Researchers measured pain and blood pressure before and after each session to see if the aromatherapy made a difference.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
geranium essential oil inhalation aromatherapy
What this could lead to
If it works, this could offer a simple, drug-free way to help cancer patients feel less pain and lower blood pressure during chemotherapy sessions.
What could go wrong
This is a small, completed trial with no phase designation, so results may not apply to all patients. Aromatherapy effects can be subtle and vary by individual, and the study did not track long-term outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

90 people

The number who actually took part.

Started

May 2022

Finished

Sep 2022

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion: 1. Cancer patients undergoing intravenous chemotherapy (regimen 1 / series 1) 2. Age less than 65 years 3. Body Mass Index (BMI) between 18.5 and 22.9 kg/m². 4. Willing to participate and able to provide informed consent. Exlusion: 1. Patients with conditions affecting the sense of smell (e.g., severe nasal obstruction or anosmia). 2. Patients with known allergies to essential oils or plant-based aromatherapy products. 3. Patients experiencing acute medical emergencies or unstable hemodynamic conditions during chemotherapy. 4. Patients who withdraw consent at any stage of the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Blood pressure changes in cancer patients are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cancer chemotherapy-induced toxicity neoplasm Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Blood pressure changes in cancer patients Cancer Chemotherapy induced pain Chemotherapy side effects

Contacts and locations

Locations

  • RSUD Dr. Moewardi Surakarta

    Surakarta, Centre Java, 57162, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.